摘要
目的：探讨头孢他啶治疗胆道感染的临床疗效。方法：对符合入选标准的96例胆道感染病人，静脉给予国产头孢他啶（商品名：新安欣，广州白云山天心制药股份有限公司）4～6g／d，同时对患者的临床症状、体征变化和不良反应进行观察，并行血、尿常规，肝、肾功能及血尿淀粉酶等检查。结果：头孢他啶对胆道感染的治疗效果良好，胆道感染痊愈率89．5％，总有效率为94．7％，无不严重不良事件发生。结论：头孢他啶对胆道感染疗效可靠并具有良好的耐受性和安全性。
Objective： To study the efficacy of ceftazidime in treatment of biliary tract infection in adult. Method： Between June 1,2004 and December 1,2005.96patients with biliary tract infection were enrolled to the trial. They were received 4 -6g ceftazidime once a day. Their symptoms and clinic sign,side effects,blood routine test,functions of liver and ren etc. were observed. Rusult： Ceftazidime presented excellent clinical efficacy in the treatment of biliary tract infection in adult patiented excellent clinical efficacy in the treatment of biliary tract infection in adult patients. The cure rate was 89.5%, total efficacy rate was 94.7%, and there are no serious side effects found. Conclusion： In summary, in adult patients with biliary tract infections, ceftazidime （4 - 6g once a day）was generally well tolerated and highly effective.
关键词
头孢他啶
胆道感染
临床研究
ceftazidime, biliary tract infection,clinical trial
